Clinical Trials Directory

Trials / Completed

CompletedNCT01375803

Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity

Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Cargill · Industry
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study will critically evaluate the effects of a novel dietary fiber administered to subjects at high risk for developing diabetes to determine if this intervention will improve insulin sensitivity compared to control product administration and, thus, decrease risk for developing diabetes. The hypothesis is that consuming this novel fiber twice a day for 12 weeks will significantly decrease fasting plasma glucose, insulin and glycosylated hemoglobin values in pre-diabetic subjects (i.e. subjects with fasting plasma glucose levels 95-140 mg/dl at screening) compared to consumption of the control product.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNovel dietary fiberoral consumption in beverage
DIETARY_SUPPLEMENTNovel dietary fiberOral consumption in beverage
OTHERPlaceboOral consumption in beverage

Timeline

Start date
2009-06-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2011-06-17
Last updated
2011-06-17

Locations

2 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01375803. Inclusion in this directory is not an endorsement.

Effects of Novel Fiber on Glucose Metabolism and Insulin Sensitivity (NCT01375803) · Clinical Trials Directory